Viewing Study NCT06738160


Ignite Creation Date: 2025-12-25 @ 2:12 AM
Ignite Modification Date: 2026-05-18 @ 7:00 AM
Study NCT ID: NCT06738160
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-07-16
First Post: 2024-12-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Efficacy and Safety of Narlumosbart in Combination With Stereotactic Body Radiation Therapy to Improve the Efficacy of First-line Chemotherapy Combined With Immunotherapy in Patients With Bone Metastases From Advanced Non-small Cell Lung Cancer
Sponsor: Fudan University
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None NSCLC View
None Stereotactic Body Radiation Therapy (SBRT) View
None Immunotherapy View
Keywords: